U.S. Online Retail and Ecommerce Stock News

Schrödinger, Inc. reported full-year 2025 results, with sales of US$56.37 million and total revenue of US$255.87 million, while reducing its net loss to US$103.27 million and basic loss per share from continuing operations to US$1.41. The combination of strong revenue growth and a substantially smaller loss suggests the company is scaling its platform while exercising tighter cost control. We’ll now examine how this sharp revenue increase and narrower loss shape Schrödinger’s existing...

IPG Photonics (NasdaqGS:IPGP) has received an adverse ruling from the Unified Patent Court in Germany in a patent infringement case with Trumpf SE & Co. KG involving adjustable mode beam lasers. The decision may lead to an injunction, product recall, or damages affecting certain products in key European markets. In parallel, the company announced a substantial follow on order from Lockheed Martin for its CROSSBOW counter UAS laser systems. At a share price of $131.57, IPG Photonics comes...

If you are wondering whether Sociedad Química y Minera de Chile shares are still offering value at current levels, this article is here to unpack what the current price might be implying about the business. The stock last closed at US$76.30, with a 6.2% return over the past 7 days, a 9.4% return year to date, a 98.9% return over 1 year, a 71.6% return over 5 years and an 8.7% decline over 30 days. This can naturally raise questions about where expectations and risks now sit. Recent headlines...

Western Midstream Partners (WES) is back in focus after its fourth quarter 2025 results missed earnings and revenue forecasts, even as management paired the release with record full-year adjusted EBITDA and higher 2026 distribution guidance. See our latest analysis for Western Midstream Partners. At a share price of $41.59, Western Midstream Partners has seen steady momentum, with a 90 day share price return of 5.75% and a 1 year total shareholder return of 12.53%, building on a very large 5...

Graphic Packaging Holding (GPK) has quickly come into focus after amending its credit agreement to allow higher leverage, while also facing legal investigations linked to projected 2026 Adjusted EBITDA pressure and prior share price weakness. See our latest analysis for Graphic Packaging Holding. The leverage covenant change, legal investigations, and recent dividend declaration all come against a backdrop of weaker share price momentum, with a 30 day share price return of 17.59% and a 1 year...

PepsiCo (NasdaqGS:PEP) is rolling out viral prebiotic soda brand Poppi in the UK, marking the drink’s first major move outside the U.S. The company is expanding its functional beverage range with a new Pepsi Prebiotic Cola, now available across the U.S. market. PepsiCo is teaming up with Jack Link’s on Doritos flavored jerky and tying Bubly to the Super Mario Galaxy Movie through themed drinks and interactive giveaways. For investors watching NasdaqGS:PEP, these launches and partnerships...

Why Genworth Financial Is On Investors’ Radar Today Genworth Financial (GNW) is back in focus after recent trading left the stock modestly lower over the week but slightly higher over the past month, prompting investors to reassess its insurance driven business mix and valuation. See our latest analysis for Genworth Financial. At a share price of US$8.44, Genworth’s recent 1 day share price decline of 2.43% and 7 day share price return of 3.87% contrast with a 1 year total shareholder return...

What recent returns tell you about Arch Capital Group (ACGL) Arch Capital Group (ACGL) has drawn fresh attention after a steady run, with the stock showing gains over the past week, month, past 3 months, year to date, and the past year. Over longer stretches, its reported 3 year and 5 year total returns are also positive, which helps frame the current share price of $100.15 that investors are reacting to today. See our latest analysis for Arch Capital Group. For context, Arch Capital Group’s...

If you are wondering whether Parker-Hannifin's current share price still offers value, this article walks through what the numbers are saying about the stock today. The shares recently closed at US$1,009.18, with returns of 10.1% over the last 30 days, 12.9% year to date, and 52.4% over 1 year, while the 3 year and 5 year returns sit at 190.3% and 259.2% respectively. This follows a 1.3% decline over the past week. Recent coverage has focused on Parker-Hannifin as a large US capital goods...

CarMax, NYSE:KMX, has launched a vehicle shopping app in the ChatGPT app store, positioning itself as the first U.S. auto retailer to offer a dedicated conversational AI car buying and selling experience. The new app allows users to search, compare, and explore CarMax’s nationwide inventory using natural language directly within ChatGPT. The move is aimed at aligning the car buying process with changing consumer habits around digital and AI assisted shopping. CarMax enters this launch with...

Earlier this week, Fannie Mae launched fixed-price cash tender offers to repurchase a wide range of Connecticut Avenue Securities notes, totaling more than US$1.20 billion in original principal, with prices above par set out in a detailed Offer to Purchase. Alongside these tenders, the company is operating against a backdrop of directed government support for its bond market, highlighting how policy and liability management can jointly shape its balance sheet and funding profile. We’ll now...

If you are wondering whether Cardinal Health's share price still reflects fair value after its strong run, you are not alone. This article will walk through what the current numbers might be telling you. The stock last closed at US$229.23, with returns of 2.1% over 7 days, 9.0% over 30 days, 11.4% year to date, 79.3% over 1 year and 221.6% over 3 years. This naturally raises questions about how much of the story is already priced in. Recent news flow around Cardinal Health has focused on its...

Why Triumph Financial is on investors’ radar today Triumph Financial (TFIN) has drawn fresh attention after a period where the stock logged a 10.4% decline over the past week and a 11.8% drop over the past month. Those short term moves come against a mixed backdrop of returns over longer horizons. This creates a natural pause point for investors assessing how the bank’s current US$55.86 share price lines up with its recent financial results. See our latest analysis for Triumph...

Supernus Pharmaceuticals reported record revenues in 2025. The company completed the integration of Sage Therapeutics. New products ONAPGO for Parkinson's disease and ZURZUVAE for postpartum depression were launched. The business expanded into new therapeutic areas despite supply constraints. For investors looking at NasdaqGM:SUPN, these company updates come with a stock that last closed at $54.73 and has returned 70.7% over the past year. Over 3 years the stock is up 37.5%, and over 5...

If you are wondering whether Trustmark's current share price lines up with its underlying value, this article is designed to walk you through that question in a clear, practical way. Trustmark's share price recently closed at US$42.59, with returns of a 4.8% decline over 7 days, 1.1% over 30 days, 9.0% year to date, 19.3% over 1 year, 59.7% over 3 years and 48.4% over 5 years. These price moves are sitting against a backdrop of ongoing interest in US regional banks. In this space, investors...

FMC Corporation recently announced that the Herbicide Resistance Action Committee classified its herbicide rimisoxafen as the first-ever dual mode of action product under HRAC Groups 12 and 32, while also declaring a regular quarterly dividend of US$0.08 per share payable on April 16, 2026, to shareholders of record on March 31, 2026. HRAC’s unprecedented dual classification underscores rimisoxafen’s potential role as an important tool against herbicide-resistant weeds such as palmer...

Magnolia Oil & Gas (MGY) has been in focus after its fourth quarter 2025 earnings slightly missed forecasts, yet the stock recently touched a 52 week high and management appeared at the THRIVE Energy Conference. See our latest analysis for Magnolia Oil & Gas. The recent move to a US$27.82 share price, alongside Magnolia Oil & Gas touching a 52 week high, comes after a 10.31% 30 day share price return and a 23.75% year to date share price return. The 5 year total shareholder return of 139.20%...

What recent performance tells you about Bio-Techne Bio-Techne (TECH) has seen mixed share performance recently, with gains of 1.9% over the past day and 2.6% over the past week, set against declines over the month and past 3 months. See our latest analysis for Bio-Techne. At a share price of US$59.0, Bio-Techne’s recent 1-day and 7-day share price gains come after a 1-year total shareholder return decline of 3.9% and a 5-year total shareholder return decline of 32.3%. This suggests short-term...

Aon plc announced that Nick Fraccalvieri was appointed CEO of global facultative for Aon’s Reinsurance Solutions, effective March 1, 2026, while retaining his EMEA facultative leadership role and succeeding Andrew Laing, who remains global chair of facultative and UK CEO. This leadership shift places ceded facultative, digital capabilities, and talent development at the center of Aon’s global facultative reinsurance ambitions in an increasingly complex risk landscape. We’ll now examine how...

Why Principal Financial Group’s shelf registration and rating change matter now Principal Financial Group (PFG) has filed an omnibus shelf registration covering common and preferred stock, debt, depositary shares, warrants, purchase contracts, and purchase units, giving the company flexibility to raise capital when needed. At the same time, a Wells Fargo analyst moved the stock to an Equal-Weight rating after mixed earnings and valuation concerns. This combination puts financing options and...

Sunrun (RUN) closed out FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.45, while trailing twelve month EPS sat at US$1.96 on revenue of US$3.0 billion. The company has seen quarterly revenue range from US$504.3 million to US$1.2 billion through 2025, with basic EPS moving from US$0.22 in Q1 to US$1.22 in Q2 and US$0.07 in Q3 before landing at US$0.45 in Q4, alongside a trailing twelve month net income of US$449.9 million. For investors, the key question now is how durable...

Terns Pharmaceuticals recently drew fresh attention after Leerink Partners initiated coverage with an Outperform rating, while hedge fund ownership in the stock climbed during the fourth quarter of 2025. The focus on TERN-701, a next-generation allosteric inhibitor for chronic myeloid leukemia, underscores how a single pipeline asset can reshape institutional interest in a clinical-stage biotech. We will now examine how this growing hedge fund interest around TERN-701 influences Terns...

If you are wondering whether Dycom Industries' share price still lines up with its underlying worth, this article will walk through what the current market price might be implying about the business. The stock recently closed at US$418.24, with returns of 13.0% over the last 30 days, 20.3% year to date, 155.2% over 1 year, 313.6% over 3 years and 377.8% over 5 years. This raises fair questions about how much optimism is already priced in. Recent news coverage has focused on Dycom Industries'...

American Express, NYSE:AXP, has announced plans to become the sole tenant of a new global headquarters at 2 World Trade Center in New York City. The company plans a state of the art tower focused on future ready technology, employee well being, and sustainability. The development is expected to play a meaningful role in the local economy and stand out as a major corporate real estate move within the financial sector. For investors watching NYSE:AXP, the new headquarters plan comes at a time...